首页> 外国专利> Compositions for testing to predict and/or diagnose allergy to penicillins

Compositions for testing to predict and/or diagnose allergy to penicillins

机译:用于测试以预测和/或诊断对青霉素过敏的组合物

摘要

The invention relates to the testing of humans or other animals, such as horses, cattle or dogs, for allergic reaction or hypersensitivity to penicillins. The tests can be used both to predict and to diagnose allergy. The invention comprises new materials for use in minor determinant mixture (MDM) compositions and lyophilized, storage- stable MDM compositions and novel test methods employing such materials. P PThe new MDM materials are N-penicilloyl amines of an aliphatic amine or &agr;-aminoacid having the following molecular structure: ##STR1## wherein: R.sub.1 =a side chain which defines the type of penicillin--e.g., where R.sub.1 = ##STR2## the new material is a derivative of benzylpenicillin; and R.sub.2 is an alkyl group of C.sub.2 - C.sub.6 length, preferably ethyl or propyl, or an aminoacid residue as described herein.PPThe tests are preferably carried out by applying solutions of the materials to the skin of the patient or other test animal and pricking or scratching the skin, or by injecting the materials intradermally, and then observing for wheal and flare reactions. The preferred test method comprises a two-solution test using a solution of the novel PPL preparations described in my copending U.S. Patent application Ser. No. 898,044 applied on or into one area of the patient's skin and a separate solution containing the new minor determinant material alone or as part of an MDM solution with other constituents applied on or into another area of the patient's skin.
机译:本发明涉及对人或其他动物,例如马,牛或狗,对青霉素的过敏反应或超敏反应的测试。这些测试可用于预测和诊断过敏。本发明包括用于次要决定因素混合物(MDM)组合物和冻干的,储存稳定的MDM组合物的新材料,以及采用这种材料的新颖测试方法。

新型MDM材料是具有以下分子结构的脂肪族胺或α-氨基酸的N-苄基胺:其中:R.sub.1 =定义类型的侧链青霉素类药物-例如,在R.sub.1 = ## STR2 ##的情况下,新材料是苄青霉素的衍生物; R 2是长度为C 2 -C 6的烷基,优选为乙基或丙基,或者如本文所述的氨基酸残基。将材料的溶液涂抹到患者或其他测试动物的皮肤上,刺破或刮擦皮肤,或通过皮内注射材料,然后观察是否有风吹和火光反应。优选的测试方法包括使用在我的共同未决的美国专利申请系列No.美国专利898,044号施加在患者皮肤的一个区域上或内,以及单独的溶液,该溶液单独或作为MDM溶液的一部分包含新的次要决定性物质,而其他成分则施加在患者皮肤的另一个区域上或内。

著录项

  • 公开/公告号US4316882A

    专利类型

  • 公开/公告日1982-02-23

    原文格式PDF

  • 申请/专利权人 LEVINE;BERNARD B.;

    申请/专利号US19790071418

  • 发明设计人 BERNARD B. LEVINE;

    申请日1979-08-30

  • 分类号A61K49/00;

  • 国家 US

  • 入库时间 2022-08-22 12:14:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号